1. Home
  2. PULM

PULM

Pulmatrix Inc.

Logo Pulmatrix Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

Founded: 2003 Country:
United States
United States
Employees: N/A City: BEDFORD
Market Cap: 7.3M IPO Year: N/A
Target Price: $10.00 AVG Volume (30 days): 15.8K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.87 EPS Growth: N/A
52 Week Low/High: $1.55 - $3.14 Next Earning Date: 05-10-2024
Revenue: $7,298,000 Revenue Growth: 20.21%
Revenue Growth (this year): -3.07% Revenue Growth (next year): 1.00%

Share on Social Networks: